Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia.

McClelland HA, Farquharson RG, Leyburn P, Furness JA, Schiff AA.

Arch Gen Psychiatry. 1976 Dec;33(12):1435-9.

PMID:
11760
2.

A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.

Chouinard G, Annable L, Campbell W.

J Clin Psychopharmacol. 1989 Aug;9(4):247-53.

PMID:
2570086
3.

Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.

MacCrimmon DJ, Saxena B, Foley P, Grof P.

Neuropsychobiology. 1978;4(6):360-5.

PMID:
692838
4.
5.

Pharmacotherapy of impaired affect in recovering schizophrenic patients.

Hogarty GE, McEvoy JP, Ulrich RF, DiBarry AL, Bartone P, Cooley S, Hammill K, Carter M, Munetz MR, Perel J.

Arch Gen Psychiatry. 1995 Jan;52(1):29.

PMID:
7811160
6.

Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome.

Marder SR, Van Putten T, Mintz J, Lebell M, McKenzie J, May PR.

Arch Gen Psychiatry. 1987 Jun;44(6):518-21.

PMID:
3555385
7.
9.

A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.

Iqbal MJ, Young MA, Charles J, Elgart B, Von Greiff H, Simpson GM.

J Clin Psychiatry. 1978 Apr;39(4):375-9.

PMID:
580285
10.

[Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms (author's transl)].

Lehmann E, Quadbeck H, Tegeler J, Fararuni M, Heinrich K.

Pharmakopsychiatr Neuropsychopharmakol. 1980 May;13(3):117-29. German.

PMID:
7393998
11.

High vs standard dosage fluphenazine HCL in acute schizophrenia.

Donlon PT, Meadow A, Tupin JP, Wahba M.

J Clin Psychiatry. 1978 Nov;39(11):800-4.

PMID:
363702
12.
13.

[Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].

Woggon B, Dick P, Fleischhauer HJ, Gmür M, Gruber G, Angst J, Heimann H.

Int Pharmacopsychiatry. 1977;12(4):193-209. German.

PMID:
22515
14.

Costs and benefits of two doses of fluphenazine.

Marder SR, Van Putten T, Mintz J, McKenzie J, Lebell M, Faltico G, May PR.

Arch Gen Psychiatry. 1984 Nov;41(11):1025-9.

PMID:
6437365
15.

A comparative trail of fluphenazine decanoate and flupenthixol decanoate.

Haslam MT, Bromham BM, Schiff AA.

Acta Psychiatr Scand. 1975 Feb;51(2):92-100.

PMID:
1091124
16.
17.

Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.

Frangos H, Zissis NP, Leontopoulos I, Diamantas N, Tsitouridis S, Gavriil I, Tsolis K.

Acta Psychiatr Scand. 1978 May;57(5):436-46.

PMID:
354331
18.

Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.

Marder SR, Midha KK, Van Putten T, Aravagiri M, Hawes EM, Hubbard JW, McKay G, Mintz J.

Br J Psychiatry. 1991 May;158:658-65.

PMID:
1860020
19.

Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates.

Kane JM, Rifkin A, Woerner M, Reardon G, Sarantakos S, Schiebel D, Ramos-Lorenzi J.

Arch Gen Psychiatry. 1983 Aug;40(8):893-6.

PMID:
6347119
20.

A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.

Dencker SJ, Frankenberg K, Malm U, Zell B.

Acta Psychiatr Scand Suppl. 1973;241:101-18. No abstract available.

PMID:
4147508

Supplemental Content

Support Center